XRaise
Sign in
SOSV
SOSV

IndieBio 2024 - DecD

AgtechBiotechData AnalyticsFoodtechHealthcare
Deadline
Dec 30, 2024
Applications
Closed
Location
California or New York
Duration
120 days

Applications are closed

The application window closed Dec 30, 2024. This page stays here for the record.

About this program

  • Program Type: hybrid (in-person and virtual)
  • Location: California or New York
  • Investment: $250k-$500k
  • Equity taken: 10%
  • Program duration: 4 months
  • Stage: Early stage.
  • Industry of Focus: Human and Planetary Health, including biology, food, biomaterials, biological tools, diagnostics, synthetic biology, genomics, and data analysis to just name a few areas.
  • Other Important Information:
  • IndieBio, an initiative by SOSV, represents a groundbreaking hybrid accelerator program situated either in California or New York, specifically designed for startups at the intersection of human and planetary health.
  • Companies can be based on hardware, software, or wet-biology and go straight to consumers or sell to business.
  • All you need to apply is a well thought out idea with the science worked out at least in principle and a good team (two co-founders minimum). We’ll help you with all the rest.
  • Anyone from anywhere can apply. You do have to be legally in California or New York during the program, of course. Once accepted, we can help with legal/immigration issues.
  • In order to attract investment, you should incorporate your company in the U.S.
  • we have accepted teams that have previously raised funding through venture capital, angel investors, or grants.
  • Our initial investment, which unlocks entry into our very selective IndieBio startup community, comprises two post-money SAFEs, executed simultaneously. The first is a Cash SAFE of $200,000 and the other is an IndieBio SAFE for all the resources, infrastructure, and services IndieBio provides to its portfolio companies. Both these SAFEs are post-debt instruments. In simple terms, this means these are diluted in a qualified priced equity financing round, but not by other SAFEs, debt or convertible notes. Based on performance against value-inflecting milestones, we also offer an additional $250,000 SAFE from the Genesis Consortium (also a post-debt instrument) at a valuation cap of $6M.
  • We don’t seek any special or controlling interests in your company. Our investor rights are quite standard. For our initial investment, we ask for a board observer seat but not a voting board seat.

Program questionnaire

26 questions

What SOSV asks on its own application. Nothing is answered here, prepare these, then apply on their site.

  1. 1

    First Name

  2. 2

    Last Name

  3. 3

    Contact Email

  4. 4

    Company name

  5. 5

    Location (city)

  6. 6

    Description, max140 characters

  7. 7

    Website

  8. 8

    Social profiles

  9. 9

    Founders Add your founders' information, including their social media presences. Name Title Email Phone

  10. 10

    Where is your team currently located? (current location doesn't affect application)